Biotech

All Articles

Former Seagen chief executive officer unveils brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2014 for an ...

Ironwood makes more purpose $1B GI drug with brand new subgroup records

.On the heels of a stage 3 succeed that neglected to impress real estate investors, Ironwood Pharmac...

Novartis inks $150M package for autoimmune molecular glue

.Do not cease Monte Rosa Rehabs currently. The Boston-based biotech is having a ball after signing a...

Jade carves out officer crew with Chinook veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial management hirings, shootings...

Septerna goes public along with upsized offering of $288M

.Commemorating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer soun...

AbbVie creates Richter wealthier, spending $25M to form discovery treaty

.AbbVie has actually gone back to the source of its own antipsychotic goliath Vraylar seeking one mo...

GenSight enters into ultimate weeks of cash path as income flow slips by of scope

.GenSight Biologics is weeks off of losing cash. Once again. The biotech only has sufficient cash to...

AZ licenses disposed of uncommon condition medication to Monopar Therapeutics

.Monopar Rehabs is actually recouping a medicine from the scrap heap of AstraZeneca's rare condition...

Arcus' brand-new HIF-2a information in renal cancer mean prospective upper hand over Merck's Welireg, professionals point out

.Along with new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of professiona...

Roche wagers around $1B to broaden Dyno genetics treatment distribution contract

.After forming a genetics treatment partnership with Dyno Therapeutics in 2020, Roche is back for mo...